Risk factors

HCW Biologics (HCWB) risk factors

Item 1A of every HCW Biologics Inc. 10-K on file, and what changed from one year to the next.

  • FY2025 10-K risk factors

    45 risks, 1 new, 2 dropped, 8 reworded since the prior year. Nasdaq listing compliance issues, ongoing going concern doubts, and significant past due liabilities dominate this company's risk profile.

    Filed Mar 31, 2026
  • FY2024 10-K risk factors

    46 risks. HCW Biologics faces going-concern doubts with significant historical losses and $17.8 million in past-due accounts payable. The company relies on a single third-party manufacturer for clinical supply and has no commercial products. Nasdaq listing compliance remains conditional under an accepted plan.

    Filed Mar 28, 2025